Why BGPT?
logo

Check Claims Before You Publish

See how your reported results read as versioned evidence records β€” linked to experiments and limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to review claims



    Explore by Goal












     Quick Explanation


    Yong Yu β€” scientific strength snapshot
    • Strong cross-domain experimental + computational output (tumor immunology/spatial omics, RCC metabolism, fungal nutrient sensing, molecular-glue toxicity, regulatory-embedding ML, etc.).
    • Most convincing work in mechanistic biology: e.g., epithelial–myeloid immunosuppression via ANXA1–FPR signaling with spatial omics and combination intervention in mice
    • Some papers are primarily in vitro / proxy-based (e.g., PPI from sequence embeddings; cell-growth chemical analogs), where generalizability and direct causal validation can be weaker



     Long Explanation


    Author Review: Yong Yu
    Evidence base: the dataset you provided lists multiple publications attributed to β€œYong Yu” with DOIs, experimental summaries, limitations, and (sometimes) data availability details. This review therefore evaluates scientific strength only from that provided evidence, without claiming additional author-wide metrics (OpenAlex timed out).
    1) Visual evidence dashboard (from your provided paper excerpts)
    2) What the evidence suggests about Yong Yu’s scientific strengths
    A. Mechanistic, multi-level validation (human + in vivo + molecular hooks)
    The clearest strength in the provided material is mechanistic layering: (i) human or multi-omic mapping, (ii) spatial or systems-level correlation, and (iii) targeted perturbation with rescue/functional endpoints.
    • OSCC spatial heterogeneity: links stage-dependent MDSC spatial redistribution to ANXA1–FPR subtype signaling and tests FPR2 blockade plus anti–PD-1 in mouse models . Main caution: the provided excerpt notes cross-sectional sampling (limited longitudinal causal inference) and computational inference dependence for ligand–receptor interaction .
    • Sepsis immunosuppression: integrates observational human cohorts (MIMIC-IV, prospective flow, CD8 RNA-seq) with murine sepsis and adoptive transfer; proposes mechanistic control via HDAC1–NFAT1 at the PDCD1 promoter and supports functional reversal by HDAC1 inhibition . Main caution: preclinical therapeutic targeting is constrained by clinical causality (observational human data) and model generalization .
    • Molecular-glue safety/on-target toxicity: uses engineered humanized CRBN mouse models, then demonstrates that protection by a non-degradable GSPT1 allele rescues toxicityβ€”this is a strong on-target validation pattern .
    B. Breadth across biological scales (cell, organism, and in silico)
    The provided set spans: (i) immune microenvironments in cancer (OSCC), (ii) metabolic transcriptional control in ccRCC (YBX1–LDHA–NF-ΞΊB), (iii) fungal nutrient sensing and virulence (Itr4), (iv) structural/biochemical protein complexes (26S proteasome recognition), (v) immunology in sepsis, and (vi) ML tooling for regulatory embeddings (ChromBERT-tools).
    • Fungal virulence via inositol sensing: frames Itr4 as a β€œtransceptor,” combines genetics, binding/uptake assays, and infection phenotypes .
    • Regulatory embedding tooling: ChromBERT-tools provides a pipeline for context-specific embeddings and demonstrates performance on BRD4 cistrome imputation with reported AUPRC improvements vs baselines . Main caution: embedding similarity is a proxy and validation is limited to selected cell types in the provided excerpt .
    C. Reproducibility signals vary by study type
    From your provided metadata, reproducibility-like scores appear higher for some β€œmechanistic and data-rich” experimental works than for proxy-only computational studies. For example, the GSPT1 toxicity paper is listed with repro score 9 , whereas some computational tool performance scores are more moderate (e.g., repro score 7 for ChromBERT-tools) .
    3) Risks, blind spots, and where the evidence is weaker
    • Cross-sectional inferential gaps: OSCC spatial work uses early/late-stage snapshots; redistribution over β€œtime” is inferred, not tracked longitudinally in the provided excerpt .
    • Proxy interaction inference: ligand–receptor maps via computational frameworks (CellPhoneDB-like approaches) can over-interpret colocalization and expression without direct binding or functional perturbation of the interaction itself .
    • Model generalization: sepsis work uses a specific pneumonia-driven model and scRNA-seq with n=8 mice; thus HDAC1 dynamics/exhaustion mechanisms may differ across sepsis etiologies .
    • Public data gaps: not all provided items mention open accession numbers (e.g., some in vitro chemical analog studies); in such cases, reproducibility assurance is weaker .
    • Computational performance β‰  causality: regulator embedding/imputation and PPI-from-sequence approaches can produce high benchmark metrics but remain proxy-based; external validation breadth matters .
    4) β€œKnown vs inferred” mapping (from provided excerpts)
    This graph is not a new measurement: it translates the provided β€œlimitations/biases” notes into a qualitative emphasis on direct vs inferential evidence. For instance, OSCC’s ligand–receptor inference is explicitly described as assumption-dependent .
    5) What would most effectively disprove the strongest claims (falsification targets)
    For OSCC ANXA1–FPR2 axis
    • Show that blocking FPR2 does not reduce MDSC accumulation or CD8 activity, and that improved anti–PD-1 efficacy does not occur in independent OSCC models .
    For HDAC1/NFAT1-mediated CD8 exhaustion in sepsis
    • Show that HDAC1 does not upregulate with exhaustion markers across cohorts/models, and that inhibiting HDAC1 does not restore CD8 function or survival .
    For GSPT1 on-target toxicity of CRBN molecular glues
    • Demonstrate that toxicity persists even when endogenous GSPT1 cannot be degraded, undermining the on-target causal link .
    6) Confidence statement about this review
    Confidence is moderate because your OpenAlex query timed out (so author-wide citation metrics weren’t pulled), and because the evidence is drawn from the provided per-paper summaries rather than full-text direct verification. However, several items include explicit limitations and data deposition statements, letting us judge rigor-to-inference balance directly from the excerpts.


    Feedback:    

    Updated: April 08, 2026

     Top Data Sources ExportMCP


     Analysis Wizard



    It will assemble a cross-paper dataframe of provided scores, sample sizes, and validation types, then generate Plotly dashboards comparing direct perturbation evidence versus proxy inference across Yong Yu publications.



     Hypothesis Graveyard


    A simple β€œonly PD-1 explains exhaustion” model is unlikely: the sepsis excerpt emphasizes AP-1/NFAT balance and promoter occupancy beyond PD-1 alone .


    A β€œligand–receptor inference alone” model for OSCC spatial immunosuppression is less favored because the excerpt includes FPR2 blockade combined with anti–PD-1 and changes in immune cell infiltrationβ€”suggesting a functional role beyond computational association .

     Science Art


    Author Review: Yong Yu Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending